USA - NASDAQ:VXRT - US92243A2006 - Common Stock
We assign a fundamental rating of 2 out of 10 to VXRT. VXRT was compared to 534 industry peers in the Biotechnology industry. Both the profitability and financial health of VXRT have multiple concerns. VXRT shows excellent growth, but is valued quite expensive already.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.66% | ||
| ROE | -127.41% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.64 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.32
-0.11 (-25.06%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.6 | ||
| P/tB | 1.94 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.66% | ||
| ROE | -127.41% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 6.2% | ||
| Cap/Sales | 1.17% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | -5.12 |
ChartMill assigns a fundamental rating of 2 / 10 to VXRT.
ChartMill assigns a valuation rating of 0 / 10 to VAXART INC (VXRT). This can be considered as Overvalued.
VAXART INC (VXRT) has a profitability rating of 1 / 10.
The financial health rating of VAXART INC (VXRT) is 1 / 10.
The Earnings per Share (EPS) of VAXART INC (VXRT) is expected to grow by 15.8% in the next year.